{
    "code": "01008311",
    "time": "2015-06-24 18:31:09",
    "許可證字號": "衛署藥製字第008311號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/05\/25",
    "發證日期": "64\/11\/27",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00100831107",
    "中文品名": "\"利達\" 利煩必新膠囊１５０公絲",
    "英文品名": "RIFAMPICIN CAPSULES 150MG \"LITA\"",
    "適應症": "肺結核、奈瑟氏腦膜炎球菌帶原者",
    "劑型": "130膠囊劑",
    "包裝": "50顆瓶裝 50顆盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "RIFAMPIN (EQ TO RIFAMPICIN) (EQ TO RIMACTAN)",
    "限制項目": [
        "01國產",
        "1G不得製造"
    ],
    "申請商名稱": "0701010200  利達製藥股份有限公司",
    "申請商地址": "台中市大甲區中山路一段９０６號",
    "主製造廠": {
        "製造廠名稱": "0701010300  利達製藥股份有限公司",
        "製造廠廠址": "台中市大甲區中山路一段９０６號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812900100",
            "成分名稱": "RIFAMPIN (EQ TO RIFAMPICIN) (EQ TO RIMACTAN)",
            "含量描述": "(POTENCY)",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 010083110002.jpg 010083110001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=01008311&Seq=002&Type=9"
        }
    ]
}